Amit Singal, MD
Enriched profileProfessor of Internal Medicine; Chief of Hepatology; Medical Director, Liver Tumor Program; Willis C. Maddrey, M.D. Distinguished Chair in Liver Disease; Dedman Family Scholar in Clinical Care · University of Texas Southwestern Medical Center
Amit Singal is Professor of Internal Medicine; Chief of Hepatology; Medical Director, Liver Tumor Program; Willis C. Maddrey, M.D. Distinguished Chair in Liver Disease; Dedman Family Scholar in Clinical Care at University of Texas Southwestern Medical Center. OpenAlex indexes 1,020 publications with 48,718 citations (h-index 98); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Gastroenterology profiles in the findmyKOL directory.
Data verified 17 Aug 2026
Overview
Updated 27 Aug 2026
Amit G. Singal, MD, is Professor of Internal Medicine at University of Texas Southwestern Medical Center, Division of Digestive and Liver Diseases, Department of Internal Medicine, Dallas, TX. The public record shows 1,020 publications with 48,718 citations (h-index 98), centered on Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 26 companies, 10 NIH-funded awards (2017–2026).
- Most recent indexed publication: 2026 · Liver international
- Top research focus: Hepatocellular Carcinoma Treatment and Prognosis
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 26 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 120 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 374.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
Sponsor: University of Texas Southwestern Medical Center
- National Liver Cancer Screening Trial
Sponsor: University of Texas Southwestern Medical Center
- Erlotinib for Hepatocellular Carcinoma Chemoprevention
Sponsor: University of Texas Southwestern Medical Center
Industry payments
Updated 27 Aug 2026
26 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- FUJIFILM CorporationProgram year20252 payments$27,883openpaymentsdata.cms.gov ↗
- AstraZeneca UK LimitedProgram year202511 payments$25,798openpaymentsdata.cms.gov ↗
- Boston Scientific CorporationProgram year202510 payments$15,503openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
62.5%Proton pump inhibitor62.5%Pantoprazole Sodium100%Part D<11 patientsAnti-infectives
37.5%Nucleoside and nucleotide reverse transcriptase inhibitors37.5%Vemlidy100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
10 NIH research awards on record, funded 2017–2026 per NIH RePORTER. The latest:
- Clinical Validation Center for Hepatocellular Carcinoma
Ut Southwestern Medical Center
FY2026$1,003,597U01CA271887 - Precision Risk Stratification and Screening for HCC among Patients with Indeterminate Liver Nodules
Ut Southwestern Medical Center
FY2025$2,104,865U01CA283935
Congress activity
Updated 27 Aug 2026
28 congress contributions (2012–2025) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic Regions.
Liver international
Article2026 - Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic.
Hepatology (Baltimore, Md.)
Review2026 - Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement.
Nature reviews. Clinical oncology
Review2026 - Updated Epidemiology of Gastrointestinal Cancers in the Asia-Pacific: Evidence From GBD 2021 and GLOBOCAN 2022.
Journal of gastroenterology and hepatology
Review2026 - Causes of mortality among patients with early-stage hepatocellular carcinoma.
Hepatology (Baltimore, Md.)
Article2026
Most-cited works
by citation count (OpenAlex)- 01Hepatocellular carcinoma6,521 citations2021
- 02
- 03
- 04
- 05Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis1,160 citations2019
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/amit-singal-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Amit-Singal
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/docamitgs
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
Mentions by others
where others cite or feature them- Other
aasld.org/liver-fellow-network/core-series/podcast/diving-deep-hcc-amit-singal
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗ - Other
aasld.org/the-liver-meeting/speakers/amit-g-singal-35785
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗ - X / Twitter
X (Twitter) handle @docamitgs
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- M.S. in Health and Health Care Research
University of Michigan
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗ - M.S. in Clinical Science (with distinction)
University of Michigan
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗ - Board Certified
Gastroenterology and Transplant Hepatology, American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →businesswire.com ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oaepublish.com ↗
- Active member with leadership responsibilities in AASLD
AGA, ACG, and ILCA
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oaepublish.com ↗ - Associate Editor
Clinical Gastroenterology and Hepatology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →us.elsevierhealth.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
Secondary affiliations
appointments beyond the home institution- Chief Medical Officer
Curve Biosciences
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →businesswire.com ↗ - Faculty
Department of Public Health, UT Southwestern Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
Media & interviews
press, podcasts and appearances- Interview: "Special Interview with Prof. Amit Singal"
Hepatoma Research / OAE Publishing, on precision HCC screening
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oaepublish.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ajmc.com ↗
- Recurring contributor/author
OncLive (liver cancer commentary)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Carol Tamminga, MD
University of Texas Southwestern Medical Center
David Karp, MD
University of Texas Southwestern Medical Center
Wanpen Vongpatanasin, MD
University of Texas Southwestern Medical Center
David Johnson, MD
University of Texas Southwestern Medical Center